Medico Remedies Ltd (MEDICO) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1002925,
    "name": "Medico Remedies",
    "stock_name": "Medico Remedies",
    "full_name": "Medico Remedies Ltd",
    "name_url": "stocks-analysis/medico-remedies",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "49.89",
    "chg": 1.76,
    "chgp": "3.66%",
    "dir": 1,
    "prev_price": "48.13",
    "mcapval": "404.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540937,
    "symbol": "MEDICO",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE630Y01024",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "1.73 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/medico-remedies-1002925-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Medico Remedies Sees Revision in Market Evaluation Amidst Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/medico-remedies-upgraded-from-sell-to-hold-by-marketsmojo-on-12-nov-2025-3746591",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MedicoRemedies_mojoScore_3746591.png",
        "date": "2025-12-04 11:08:06",
        "description": "Medico Remedies, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting a nuanced shift in its financial and technical outlook. This adjustment follows a detailed reassessment of the company’s quality, valuation, financial trends, and technical indicators, offering investors a refreshed perspective on its market position."
      },
      {
        "title": "Medico Remedies Forms Golden Cross, Signalling Potential Bullish Breakout",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medico-remedies-forms-golden-cross-signalling-potential-bullish-breakout-3739076",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MedicoRemedies_goldencross_3739076.png",
        "date": "2025-12-01 18:00:23",
        "description": "Medico Remedies, a player in the Pharmaceuticals & Biotechnology sector, has recently formed a Golden Cross, a significant technical indicator where the 50-day moving average crosses above the 200-day moving average. This development often signals a potential shift towards a bullish trend and long-term momentum in the stock’s price movement."
      },
      {
        "title": "Is Medico Remedies overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-medico-remedies-overvalued-or-undervalued-3734669",
        "imagepath": "",
        "date": "2025-11-28 08:23:07",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Current Valuation Metrics and Market Performance</strong></p>\n<p>As of 27 Nov 2025, Medico Remedies trades at a price of ₹51.00, slightly up from the previous close of ₹49.86. The stock has experienced a 52-week price range between ₹35.00 and ₹79.78, indicating significant volatility over the past year. Despite a modest weekly return of 0.1%, the stock has outperformed the Sensex over the past month with a 4.27% gain compared to the benchmark’s 1.11%. However, year-to-date returns remain negative at -6.3%, contrasting with the Sensex’s positive 9.7%.</p>\n<p>Longer-term performance shows a mixed picture. While the stock has delivered an impressive 1258.19% return over five years, it has underperformed the Sensex over three years, with a negative 10.16% return versus the Sensex’s 37.61%. This ..."
      },
      {
        "title": "How has been the historical performance of Medico Remedies?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-medico-remedies-3699641",
        "imagepath": "",
        "date": "2025-11-13 23:44:51",
        "description": "Answer:\nThe historical performance of Medico Remedies shows a consistent growth trend in net sales and profits over the years.\n\nBreakdown:\nMedico Remedies has demonstrated a steady increase in net sales, rising from 97.69 Cr in Mar'19 to 150.94 Cr in Mar'25. The total operating income has followed a similar trajectory, reaching 150.94 Cr in Mar'25, up from 144.92 Cr in Mar'24 and 140.44 Cr in Mar'23. The company's operating profit (PBDIT) has also improved significantly, climbing to 17.69 Cr in Mar'25 from 15.04 Cr in Mar'24 and 13.57 Cr in Mar'23. Profit before tax has increased to 13.50 Cr in Mar'25, compared to 11.33 Cr in Mar'24 and 10.10 Cr in Mar'23, while profit after tax reached 10.09 Cr in Mar'25, up from 8.29 Cr in Mar'24. The company's total assets have expanded to 119.55 Cr in Mar'25 from 96.20 Cr in Mar'24, and total liabilities have also increased to 119.55 Cr in Mar'25 from 96.20 Cr in Mar'24..."
      },
      {
        "title": "Medico Remedies Shows Strong Financial Growth Amidst Stakeholder Confidence Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/medico-remedies-upgraded-to-hold-amid-mildly-bullish-outlook-3696708",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/MedicoRemedies_mojoScore_3696708.png",
        "date": "2025-11-13 08:25:08",
        "description": "Medico Remedies, a microcap in the Pharmaceuticals & Biotechnology sector, has recently adjusted its evaluation, indicating a shift in market sentiment. The company reported strong financial metrics, including a low Debt to EBITDA ratio and significant growth in operating profit and net sales, despite facing some challenges with promoter confidence."
      },
      {
        "title": "How has been the historical performance of Medico Remedies?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-medico-remedies-3695640",
        "imagepath": "",
        "date": "2025-11-13 00:33:37",
        "description": "Answer:\nThe historical performance of Medico Remedies shows a consistent growth trend in net sales and profitability over the years.\n\nBreakdown:\nMedico Remedies has demonstrated a steady increase in net sales, rising from 97.69 Cr in Mar'19 to 150.94 Cr in Mar'25. This growth is accompanied by a rise in total operating income, which reached 150.94 Cr in Mar'25, up from 144.92 Cr in Mar'24. The company's operating profit (PBDIT) has also improved significantly, climbing to 17.69 Cr in Mar'25 from 4.66 Cr in Mar'19, indicating enhanced operational efficiency. Profit before tax has followed a similar upward trajectory, reaching 13.50 Cr in Mar'25 compared to just 2.18 Cr in Mar'19. Consequently, profit after tax has increased to 10.09 Cr in Mar'25 from 1.57 Cr in Mar'19, reflecting a growing profitability margin, which stands at 6.68% in Mar'25. On the balance sheet, total assets have expanded to 119.55 Cr in ..."
      },
      {
        "title": "Why is Medico Remedies falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-medico-remedies-fallingrising-3687348",
        "imagepath": "",
        "date": "2025-11-10 23:51:16",
        "description": "As of 10-Nov, Medico Remedies Ltd is experiencing a price increase, currently at Rs 51.50, reflecting a rise of Rs 1.55 or 3.1%. The stock has shown a positive trend today, outperforming its sector by 2.05% and reversing a two-day decline. It reached an intraday high of Rs 52.44, marking a 4.98% increase. Over the past week, the stock has gained 3.10%, while its performance over the last month is also positive at 2.81%. Despite a year-to-date decline of 5.38%, the company has demonstrated strong fundamentals, including a low Debt to EBITDA ratio of 0.94 times and significant growth in operating profit at an annual rate of 42.16%. However, the stock has underperformed over the past year with a return of -11.68%, despite a 20.7% increase in profits, indicating a potentially expensive valuation.\n\nBroader market context shows that while Medico Remedies has outperformed the sector recently, it has lagged behind ..."
      },
      {
        "title": "When is the next results date for Medico Remedies?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-medico-remedies-3681320",
        "imagepath": "",
        "date": "2025-11-07 23:21:01",
        "description": "The next results date for Medico Remedies is scheduled for 13 November 2025...."
      }
    ],
    "total": 149,
    "sid": "1002925",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/medico-remedies-1002925"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order",
      "datetime": "27-Jan-2026",
      "details": "Please find attached requisite disclosure",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order",
      "datetime": "20-Jan-2026",
      "details": "Please find attached Intimation under Regulation 30 of SEBI LODR Regulations 2025",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "30-Dec-2025",
      "details": "Please find enclosed disclosure with regards to closure of trading window",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Medico Remedies Ltd has announced <strong>2:10</strong> stock split, ex-date: 16 Mar 23",
          "dt": "2023-03-16",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Medico Remedies Ltd has announced <strong>3:1</strong> bonus issue, ex-date: 16 Nov 21",
          "dt": "2021-11-16",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Medico Remedies Sees Revision in Market Evaluation Amidst Mixed Financial Signals

2025-12-04 11:08:06

Medico Remedies, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting a nuanced shift in its financial and technical outlook. This adjustment follows a detailed reassessment of the company’s quality, valuation, financial trends, and technical indicators, offering investors a refreshed perspective on its market position.

Medico Remedies Forms Golden Cross, Signalling Potential Bullish Breakout

2025-12-01 18:00:23

Medico Remedies, a player in the Pharmaceuticals & Biotechnology sector, has recently formed a Golden Cross, a significant technical indicator where the 50-day moving average crosses above the 200-day moving average. This development often signals a potential shift towards a bullish trend and long-term momentum in the stock’s price movement.

Is Medico Remedies overvalued or undervalued?

2025-11-28 08:23:07

Current Valuation Metrics and Market Performance As of 27 Nov 2025, Medico Remedies trades at a price of ₹51.00, slightly up from the previous close of ₹49.86. The stock has experienced a 52-week price range between ₹35.00 and ₹79.78, indicating significant volatility over the past year. Despite a modest weekly return of 0.1%, the stock has outperformed the Sensex over the past month with a 4.27% gain compared to the benchmark’s 1.11%. However, year-to-date returns remain negative at -6.3%, contrasting with the Sensex’s positive 9.7%. Longer-term performance shows a mixed picture. While the stock has delivered an impressive 1258.19% return over five years, it has underperformed the Sensex over three years, with a negative 10.16% return versus the Sensex’s 37.61%. This ...

How has been the historical performance of Medico Remedies?

2025-11-13 23:44:51

Answer: The historical performance of Medico Remedies shows a consistent growth trend in net sales and profits over the years. Breakdown: Medico Remedies has demonstrated a steady increase in net sales, rising from 97.69 Cr in Mar'19 to 150.94 Cr in Mar'25. The total operating income has followed a similar trajectory, reaching 150.94 Cr in Mar'25, up from 144.92 Cr in Mar'24 and 140.44 Cr in Mar'23. The company's operating profit (PBDIT) has also improved significantly, climbing to 17.69 Cr in Mar'25 from 15.04 Cr in Mar'24 and 13.57 Cr in Mar'23. Profit before tax has increased to 13.50 Cr in Mar'25, compared to 11.33 Cr in Mar'24 and 10.10 Cr in Mar'23, while profit after tax reached 10.09 Cr in Mar'25, up from 8.29 Cr in Mar'24. The company's total assets have expanded to 119.55 Cr in Mar'25 from 96.20 Cr in Mar'24, and total liabilities have also increased to 119.55 Cr in Mar'25 from 96.20 Cr in Mar'24...

Medico Remedies Shows Strong Financial Growth Amidst Stakeholder Confidence Concerns

2025-11-13 08:25:08

Medico Remedies, a microcap in the Pharmaceuticals & Biotechnology sector, has recently adjusted its evaluation, indicating a shift in market sentiment. The company reported strong financial metrics, including a low Debt to EBITDA ratio and significant growth in operating profit and net sales, despite facing some challenges with promoter confidence.

How has been the historical performance of Medico Remedies?

2025-11-13 00:33:37

Answer: The historical performance of Medico Remedies shows a consistent growth trend in net sales and profitability over the years. Breakdown: Medico Remedies has demonstrated a steady increase in net sales, rising from 97.69 Cr in Mar'19 to 150.94 Cr in Mar'25. This growth is accompanied by a rise in total operating income, which reached 150.94 Cr in Mar'25, up from 144.92 Cr in Mar'24. The company's operating profit (PBDIT) has also improved significantly, climbing to 17.69 Cr in Mar'25 from 4.66 Cr in Mar'19, indicating enhanced operational efficiency. Profit before tax has followed a similar upward trajectory, reaching 13.50 Cr in Mar'25 compared to just 2.18 Cr in Mar'19. Consequently, profit after tax has increased to 10.09 Cr in Mar'25 from 1.57 Cr in Mar'19, reflecting a growing profitability margin, which stands at 6.68% in Mar'25. On the balance sheet, total assets have expanded to 119.55 Cr in ...

Why is Medico Remedies falling/rising?

2025-11-10 23:51:16

As of 10-Nov, Medico Remedies Ltd is experiencing a price increase, currently at Rs 51.50, reflecting a rise of Rs 1.55 or 3.1%. The stock has shown a positive trend today, outperforming its sector by 2.05% and reversing a two-day decline. It reached an intraday high of Rs 52.44, marking a 4.98% increase. Over the past week, the stock has gained 3.10%, while its performance over the last month is also positive at 2.81%. Despite a year-to-date decline of 5.38%, the company has demonstrated strong fundamentals, including a low Debt to EBITDA ratio of 0.94 times and significant growth in operating profit at an annual rate of 42.16%. However, the stock has underperformed over the past year with a return of -11.68%, despite a 20.7% increase in profits, indicating a potentially expensive valuation. Broader market context shows that while Medico Remedies has outperformed the sector recently, it has lagged behind ...

When is the next results date for Medico Remedies?

2025-11-07 23:21:01

The next results date for Medico Remedies is scheduled for 13 November 2025....

View All News